The results showed that the levels of serum type II collagen degradation (sColl2-1) and COMP were both significantly lower in adult patients with severe hemophilia A than in controls, the concentrations of cartilage turnover biomarkers in patients with on-demand treatment were lower than prophylaxis, despite being without significant differences. Here, COMP is linked to hemophilia A.